Hims & Hers Health, Inc. (DE:82W)
NYSE:82W
82W Stock Chart & Stats
€24.68
-€0.66(-2.50%)
At close: 4:00 PM EST
€24.68
-€0.66(-2.50%)
Day’s Range― - ―
52-Week Range€11.82 - €61.70
Previous CloseN/A
Volume1.67K
Average Volume (3M)1.76K
Market Cap
€5.36B
Enterprise Value€6.74B
Total Cash (Recent Filing)€750.88M
Total Debt (Recent Filing)€1.13B
Price to Earnings (P/E)―
Beta1.84
Next Earnings
Aug 10, 2026EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding223,080,080
10 Day Avg. Volume2,570
30 Day Avg. Volume1,757
Financial Highlights & Ratios
PEG Ratio-33.00
Price to Book (P/B)13.50
Price to Sales (P/S)3.11
P/FCF Ratio98.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€23.75Price Target Upside-3.76% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)-0.04
Revenue Forecast (FY)€2.50B
Bulls Say, Bears Say
Bulls Say
Revenue And Subscriber MomentumRaised full-year guidance and solid Q1 sales signal durable demand and expanding market penetration. A base of ~2.6M subscribers and recurring subscription cadence supports predictable revenue, allowing scale benefits in marketing and fulfillment as cohorts compound over months.
Strong Cash Generation And LiquidityPositive operating and free cash flow plus a large cash stockpile underpins self-funded growth, funding tech, international expansion and working capital. Reliable cash conversion reduces reliance on external financing for near-term investments and provides flexibility for opportunistic M&A or buybacks.
International Scale And Tech/AI InvestmentsAcquisitions and localized operations create scale across multiple regulated markets, increasing addressable population and regulatory know-how. Combined with AI, provider copilots, labs capabilities and platform rearchitecture, this builds durable network effects and product-launch leverage globally.
Bears Say
Elevated Leverage And Balance-Sheet RiskMaterial rise in leverage reduces financial flexibility and raises refinancing and covenant risk if cash flows falter. Higher indebtedness increases interest and funding pressure, constraining capital allocation and making the firm more sensitive to cyclical slowdowns or execution slips.
Margin Pressure And GAAP Volatility From Strategic PivotTransitioning to lower-margin specialties and shorter shipping cadences introduces lasting margin mix risk and revenue-recognition volatility. One-time charges and a Q1 GAAP loss signal the pivot can compress margins and produce uneven reported results while the business repositions.
Convertible Notes And Potential DilutionLarge convertible issuance increases future equity overhang and complicates capital structure. Conversion or redemption dynamics can dilute existing shareholders, and contingent obligations may limit strategic flexibility or raise cash needs if market conditions require refinancing.
Hims & Hers Health News
82W FAQ
What was Hims & Hers Health, Inc.’s price range in the past 12 months?
Hims & Hers Health, Inc. lowest stock price was €11.81 and its highest was €61.70 in the past 12 months.
What is Hims & Hers Health, Inc.’s market cap?
Hims & Hers Health, Inc.’s market cap is €5.36B.
When is Hims & Hers Health, Inc.’s upcoming earnings report date?
Hims & Hers Health, Inc.’s upcoming earnings report date is Aug 10, 2026 which is in 56 days.
How were Hims & Hers Health, Inc.’s earnings last quarter?
Hims & Hers Health, Inc. released its earnings results on May 11, 2026. The company reported -€0.344 earnings per share for the quarter, missing the consensus estimate of €0.022 by -€0.366.
Is Hims & Hers Health, Inc. overvalued?
According to Wall Street analysts Hims & Hers Health, Inc.’s price is currently Overvalued.
Does Hims & Hers Health, Inc. pay dividends?
Hims & Hers Health, Inc. does not currently pay dividends.
What is Hims & Hers Health, Inc.’s EPS estimate?
Hims & Hers Health, Inc.’s EPS estimate is -0.04.
How many shares outstanding does Hims & Hers Health, Inc. have?
Hims & Hers Health, Inc. has 223,080,080 shares outstanding.
What happened to Hims & Hers Health, Inc.’s price movement after its last earnings report?
Hims & Hers Health, Inc. reported an EPS of -€0.344 in its last earnings report, missing expectations of €0.022. Following the earnings report the stock price went up 18.684%.
Which hedge fund is a major shareholder of Hims & Hers Health, Inc.?
Currently, no hedge funds are holding shares in DE:82W
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hims & Hers Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€23.75 (-3.76% Downside)
€23.75 (-3.76% Downside)
Blogger Sentiment
Bullish
DE:82W Sentiment 84%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth €1.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.07%
12-Months-Change
Fundamentals
Return on Equity
-2.48%
Trailing 12-Months
Asset Growth
154.24%
Trailing 12-Months
Company Description
Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
82W Company Deck
82W Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a mix of near-term headwinds tied to a deliberate strategic pivot (one-time restructuring charges, gross-margin pressure, GAAP loss and short-term volatility) alongside several strong growth signals: raised full-year revenue guide, rapid adoption of branded GLP-1 products (125k+ Wegovy shipments in six weeks and on track for >100k monthly subscribers), international revenue growth (~10x to $78M), positive operating cash flow ($89M) and deep investments in AI, labs and verticalized supply chain. Management expects accelerating EBITDA in H2 as monthly cohorts compound and efficiencies emerge. Given the substantial operational and commercial progress and the forward-looking guidance offsetting temporary accounting and margin noise, the positive operational momentum and upgraded outlook outweigh the short-term financial disruptions.View all DE:82W earnings summaries82W Revenue Breakdown
96.60% Online
3.40% Wholesale
82W Stock 12 Month Forecast
Average Price Target
€23.75
▼(-3.76% Downside)
Technical Analysis
Options Prices
Currently, No data available
---